STD testing among pregnant women in the United States, 2011-2015
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.


This Document Has Been Replaced By:



This Document Has Been Retired


Up-to-date Information

This is the latest update:

STD testing among pregnant women in the United States, 2011-2015
  • Published Date:

    Feb 2020

  • Source:
    Sex Health. 17(1):1-8
  • Language:

Public Access Version Available on: February 01, 2021, 12:00 AM information icon
Please check back on the date listed above.
  • Alternative Title:
    Sex Health
  • Description:
    Introduction: Sexually transmitted diseases (STDs) are increasing in the United States. Pregnant women and infants are susceptible to serious STD-related sequelae; however, some STDs can be cured during pregnancy with appropriate, timely screening. Methods: We used data from the 2011–2015 National Survey of Family Growth to examine STD testing (in the past 12 months) among women who were pregnant in the past 12 months (n=1,155). In bivariate and multivariable analyses, we examined associations between demographics, health care access and two outcome variables – receipt of chlamydia test and receipt of other STD test. Results: Among women who were pregnant in the past 12 months, 48% reported receiving a chlamydia test and 54% reported that they received a STD test other than chlamydia in the past 12 months. In adjusted analyses, non-Hispanic black women were more likely to receive a chlamydia test (aOR=2.82, 1.86–4.26) and other STD test (aOR=2.43, 1.58–3.74) than non-Hispanic white women. Women living in a metropolitan statistical area but not the principal city were less likely to report chlamydia (aOR=0.62, 0.44–0.86) and other STD testing (aOR=0.57, 0.40–0.81) than women living in a principal city. Women born outside of the U.S. were significantly less likely to have received a chlamydia test (aOR=0.35, 0.19–0.64) or other STD test (aOR=0.34, 0.20–0.58) while those who had received prenatal care were more likely to receive a chlamydia test (aOR=2.10, 1.35–3.28) or other STD test (aOR=2.32, 1.54–3.49). Conclusions: Our findings suggest that interventions are needed to increase adherence to recommended STD screenings during pregnancy.
  • Pubmed ID:
  • Pubmed Central ID:
  • Document Type:
  • Collection(s):
  • Main Document Checksum:
  • File Type:
  • Supporting Files:
    No Additional Files
No Related Documents.

You May Also Like: